v.milanovi
TL3 Regular · Montpellier, FR
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 24 August 2024 · last posted 13h
132 posts, newest first. Showing up to 150.
-
Composite endpoints and the component doing the work Replied, post #8 · Evidence › Trials · 27 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #111 · Compounds › Semaglutide · 27 Jul 2026 · 0 likes Worth separating two things that post #107 runs together. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #56 · Compounds › Repair & healing peptides · 26 Jul 2026 · 0 likes Worth separating two things that post #52 runs together. The absence of adequately powered published randomised human trials is the central fact about BPC-157. This…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #77 · Sourcing › Regulatory · 26 Jul 2026 · 0 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #46 · Compounds › Retatrutide · 25 Jul 2026 · 3 likes post #45 answers the question as asked. The question underneath it is different. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
-
Sleep quality changes during weight loss Replied, post #24 · Wellbeing › Sleep · 20 Jul 2026 · 3 likes I read post #22 twice before replying, because I had assumed the opposite. Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite…
-
Follow-up: Sleep quality changes during weight loss Replied, post #74 · Wellbeing › Sleep · 19 Jul 2026 · 0 likes post #73 is right about the mechanism and I think understates the practical bit. Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs…
-
Request: a per-category review queue Replied, post #115 · Meta › Feature requests · 19 Jul 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #92 · Analytics › Impurities & related substances · 19 Jul 2026 · 1 like Coming back to post #90, because the follow-up matters more than the original answer. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #23 · Evidence › Study critique · 19 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #79 · Start Here › Welcome · 13 Jul 2026 · 27 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #22 · Practice › Dosing & titration · 11 Jul 2026 · 1 like The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Athletes in weight-category sports: a different risk calculus Replied, post #19 · Clinical › Special populations · 9 Jul 2026 · 30 likes This follows post #16 rather than contradicting it. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #7 · Start Here › How to Ask · 9 Jul 2026 · 16 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
CJC-1295 with and without DAC: what the modification does Replied, post #103 · Compounds › Secretagogues & GH axis · 5 Jul 2026 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #32 · Documentation › Doc review · 29 Jun 2026 · 0 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Insurance and replacement policies, compared Replied, post #28 · Sourcing › Logistics · 18 Jun 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Blinding yourself: practical methods and their limits Replied, post #34 · Research Methods › N-of-1 designs · 15 Jun 2026 · 12 likes post #33 is right about the mechanism and I think understates the practical bit. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #31 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 31 likes This follows post #28 rather than contradicting it. System suitability testing: injections run before and during the sample run to establish whether the instrument,…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #5 · Sourcing › Logistics · 12 Jun 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #52 · Outcomes › Progress reports · 29 May 2026 · 3 likes I read post #50 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #7 · Access › Shortages · 29 May 2026 · 0 likes Picking up post #4: that is the part I would want checked first. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #62 · Compounds › Repair & healing peptides · 29 May 2026 · 15 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Alcohol: what is documented and what is folklore Replied, post #27 · Practice › Interactions · 25 May 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Search filters: what is missing Replied, post #110 · Meta › Site feedback · 24 May 2026 · 0 likes Picking up post #107: that is the part I would want checked first. Navigation problems: if you cannot find something you expected to exist, or the path to it is…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #72 · Compounds › Tirzepatide · 21 May 2026 · 3 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
How much fluid is actually needed, and how you would know Replied, post #6 · marked as the solution · Nutrition & Training › Hydration & electrolytes · 14 May 2026 · 7 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #64 · Data & Tools › Datasets · 12 May 2026 · 4 likes On post #60 — agreed on the reasoning, with one qualification. Community-collected datasets: some members have compiled datasets from their own experience and shared…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #41 · Sourcing › Red flags · 5 May 2026 · 25 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #56 · Practice › Administration · 2 May 2026 · 2 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #83 · Practice › Reconstitution · 23 Apr 2026 · 1 like Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #62 · Practice › Reconstitution · 21 Apr 2026 · 23 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #8 · Practice › Reconstitution · 12 Apr 2026 · 16 likes I read post #6 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #50 · Practice › Administration · 11 Apr 2026 · 7 likes post #49 answers the question as asked. The question underneath it is different. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer…
-
Sample handling between despatch and injection Replied, post #24 · Analytics › Method validation · 7 Apr 2026 · 25 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Revisiting: Absolute versus relative contraindications Replied, post #60 · Safety › Contraindications · 6 Apr 2026 · 0 likes Coming back to post #58, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #10 · Devices › Syringes & needles · 5 Apr 2026 · 24 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #29 · Sourcing › Logistics · 30 Mar 2026 · 20 likes On post #25 — agreed on the reasoning, with one qualification. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before…
-
The headache that turns out to be dehydration — the long version Replied, post #15 · Nutrition & Training › Hydration & electrolytes · 30 Mar 2026 · 13 likes On post #11 — agreed on the reasoning, with one qualification. Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #3 · Analytics › Home & field testing · 28 Mar 2026 · 9 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #26 · Compounds › Repair & healing peptides · 23 Mar 2026 · 11 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
A single out-of-range value on an otherwise normal panel Replied, post #25 · Clinical › Bloodwork · 20 Mar 2026 · 7 likes Picking up post #22: that is the part I would want checked first. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #2 · Compounds › Repair & healing peptides · 18 Mar 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups,…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #23 · Analytics › COA interpretation · 12 Mar 2026 · 7 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Amylin receptor signalling and satiety — what changed since Replied, post #43 · Pharmacology › Receptor biology · 11 Mar 2026 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #65 · Pharmacology › Pharmacokinetics · 9 Mar 2026 · 13 likes This follows post #62 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Second pass at: Identical chromatograms across two different lots Replied, post #40 · Sourcing › Red flags · 3 Mar 2026 · 32 likes post #39 answers the question as asked. The question underneath it is different. Exaggerated claims without documentation: every compound has limits. No peptide is…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #136 · Access › International · 28 Feb 2026 · 3 likes On post #132 — agreed on the reasoning, with one qualification. Customs and import outcomes: different routes have different seizure rates. Some countries are stricter…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #57 · Analytics › Impurities & related substances · 17 Feb 2026 · 16 likes post #56 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #74 · Meta › Site feedback · 17 Feb 2026 · 24 likes On post #70 — agreed on the reasoning, with one qualification. Feature requests: if the site would work better with a feature it does not have (better search, different…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #69 · Analytics › Mass spectrometry · 14 Feb 2026 · 0 likes On post #65 — agreed on the reasoning, with one qualification. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large…
-
Forced degradation studies: designing one that is informative Replied, post #6 · Analytics › Method validation · 12 Feb 2026 · 22 likes On post #2 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Tag proliferation and whether we should prune — what changed since Replied, post #8 · Meta › Site feedback · 8 Feb 2026 · 6 likes post #7 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: What pooling buys you and what it destroys Replied, post #16 · Evidence › Meta-analyses · 7 Feb 2026 · 25 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #81 · Sourcing › Red flags · 7 Feb 2026 · 1 like Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #95 · Compounds › Oral incretins · 3 Feb 2026 · 12 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #44 · Clinical › Bloodwork · 1 Feb 2026 · 0 likes Picking up post #41: that is the part I would want checked first. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #40 · Documentation › Wiki requests · 16 Jan 2026 · 10 likes Coming back to post #38, because the follow-up matters more than the original answer. Accessibility feedback: if you have trouble accessing or reading a maintained page…
-
Aggregates and why a purity assay may miss them entirely Replied, post #8 · Analytics › Impurities & related substances · 14 Dec 2025 · 4 likes This follows post #5 rather than contradicting it. Related substances: compounds chemically related to the target peptide but not the target peptide itself. The…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #3 · Practice › Storage & stability · 7 Dec 2025 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #107 · Documentation › Doc review · 6 Dec 2025 · 5 likes On post #103 — agreed on the reasoning, with one qualification. Evidence synthesis requests: if you think a page should summarise the state of evidence on a question,…
-
Pen dose counters: what a click does and does not guarantee Replied, post #87 · Devices › Pens & autoinjectors · 18 Nov 2025 · 33 likes post #86 answers the question as asked. The question underneath it is different. Dose counters: pens show the remaining number of doses. When the counter reaches zero,…
-
[2026 update] What steady state means for the decision to escalate Replied, post #72 · Practice › Dosing & titration · 12 Nov 2025 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Documentation that appears only after payment Replied, post #71 · Sourcing › Red flags · 8 Nov 2025 · 1 like Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Realistic expectations for strength while losing weight quickly Replied, post #32 · Nutrition & Training › Resistance training · 30 Oct 2025 · 0 likes post #31 answers the question as asked. The question underneath it is different. Recovery: heavier training on a energy deficit and on a compound that slows gastric…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #85 · Practice › Reconstitution · 24 Oct 2025 · 11 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Publishing an inconvenient result: a case study — the long version Replied, post #13 · Sourcing › Independent verification · 19 Oct 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #22 · Compounds › Semaglutide · 7 Oct 2025 · 29 likes Picking up post #19: that is the part I would want checked first. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #56 · Practice › Dosing & titration · 25 Sep 2025 · 0 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Reading an interaction checker output critically Replied, post #8 · Practice › Interactions · 20 Sep 2025 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #17 · Compounds › Semaglutide · 19 Sep 2025 · 0 likes post #16 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: Why appetite effects are mostly central Replied, post #44 · Pharmacology › Receptor biology · 18 Sep 2025 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
High-resolution MS on aggregates and what it can see Replied, post #69 · Analytics › Mass spectrometry · 16 Sep 2025 · 4 likes Picking up post #66: that is the part I would want checked first. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057,…
-
MHRA statements, read directly Started this topic · Regional › UK & Ireland · 4 Sep 2025 · 47 likes MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
-
When a preprint is the best available evidence and we say so Replied, post #115 · Evidence › Preprints · 30 Aug 2025 · 0 likes Picking up post #112: that is the part I would want checked first. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data,…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #9 · Documentation › Doc review · 27 Aug 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #90 · Compounds › Secretagogues & GH axis · 23 Aug 2025 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #67 · Evidence › Journal club · 19 Aug 2025 · 29 likes post #66 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Thyroid function tests during substantial weight change Replied, post #31 · Clinical › Bloodwork · 15 Aug 2025 · 2 likes Worth separating two things that post #27 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #18 · Evidence › Journal club · 14 Aug 2025 · 17 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Insomnia at a dose step: reported experiences Replied, post #4 · Wellbeing › Sleep · 9 Aug 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #27 · Devices › Pens & autoinjectors · 29 Jul 2025 · 5 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
Publishing an inconvenient result: a case study Replied, post #54 · Sourcing › Independent verification · 23 Jul 2025 · 8 likes Picking up post #51: that is the part I would want checked first. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest…
-
Canadian access and provincial variation — one year on Replied, post #21 · Regional › North America · 23 Jul 2025 · 4 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
-
A field-by-field walk through a certificate of analysis Replied, post #80 · Analytics › COA interpretation · 16 Jul 2025 · 7 likes post #79 is right about the mechanism and I think understates the practical bit. When a document puts the specification in the result column, it has told you the…
-
Why the timeline is on the right and not the left Replied, post #30 · Meta › Site feedback · 17 Jun 2025 · 0 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Reading an MS report that only gives you a single number Replied, post #107 · Analytics › Mass spectrometry · 14 Jun 2025 · 5 likes Worth separating two things that post #103 runs together. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #13 · Access › Insurance & coverage · 7 Jun 2025 · 7 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #11 · Evidence › Trials · 3 Jun 2025 · 21 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
What I would record differently if I started again — the long version Started this topic · Outcomes › Progress reports · 22 May 2025 · 38 likes What I would record differently if I started again — the long version I have a specific reason for asking rather than idle curiosity, and the context is below.…
-
Pregnancy as an absolute contraindication Replied, post #18 · Safety › Contraindications · 17 May 2025 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #31 · Evidence › Trials · 16 May 2025 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #116 · Compounds › Cagrilintide & amylin analogues · 16 May 2025 · 8 likes post #115 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #40 · Practice › Reconstitution · 20 Apr 2025 · 23 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Coverage for the indication versus for the drug Replied, post #32 · Access › Insurance & coverage · 17 Apr 2025 · 1 like Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
A well-designed study with a badly written abstract Replied, post #20 · Evidence › Study critique · 12 Apr 2025 · 0 likes This follows post #17 rather than contradicting it. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to…
-
Reading a chromatogram someone posted without axes Replied, post #19 · Analytics › HPLC & UHPLC · 8 Apr 2025 · 0 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #122 · Sourcing › Regulatory · 6 Apr 2025 · 16 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 6 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #108 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #63 · Sourcing › Regulatory · 2 Mar 2025 · 6 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #21 · Sourcing › Independent verification · 2 Mar 2025 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Service differences on vendor pages: Janoshik and Medutest results are…
-
Consistent declarations and why they matter more than clever ones Replied, post #110 · Sourcing › Logistics · 2 Mar 2025 · 0 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #27 · Sourcing › Regulatory · 28 Feb 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Consistent declarations and why they matter more than clever ones Replied, post #73 · Sourcing › Logistics · 23 Feb 2025 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #66 · Analytics › Mass spectrometry · 22 Feb 2025 · 16 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Protein density versus volume when you cannot eat much Replied, post #99 · Nutrition & Training › Protein & intake · 9 Feb 2025 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
A promotion I argued against, and why I lost Replied, post #82 · Documentation › Doc review · 1 Feb 2025 · 0 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #6 · Documentation › Doc review · 29 Jan 2025 · 0 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #69 · Data & Tools › Calculators · 29 Jan 2025 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Titration planning: a calculator that shows you the escalation schedule for different…
-
Reading a supplementary appendix and finding the interesting part Replied, post #77 · Evidence › Trials · 26 Jan 2025 · 5 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #93 · Evidence › Journal club · 15 Jan 2025 · 3 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #29 · Compounds › Secretagogues & GH axis · 13 Jan 2025 · 19 likes post #28 answers the question as asked. The question underneath it is different. Ipamorelin selectivity claims originate in preclinical characterisation and are…
-
Follow-up: Individual participant data versus aggregate data Replied, post #63 · Evidence › Meta-analyses · 10 Jan 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What we do not know about retatrutide, listed explicitly Replied, post #47 · Compounds › Retatrutide · 7 Jan 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #15 · Evidence › Meta-analyses · 6 Jan 2025 · 0 likes post #14 answers the question as asked. The question underneath it is different. Publication bias: what did not get published? Small studies with negative results are…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #144 · Compounds › Oral incretins · 29 Dec 2024 · 8 likes On post #140 — agreed on the reasoning, with one qualification. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority…
-
Body image changing more slowly than the body Replied, post #100 · Wellbeing › Mental health · 22 Dec 2024 · 0 likes I read post #98 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
What changed in 2026, by region Replied, post #30 · Access › International · 19 Dec 2024 · 7 likes I read post #28 twice before replying, because I had assumed the opposite. Regulatory position dates: a regulatory position is only current as of when it was written.…
-
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #5 · Compounds › Semaglutide · 6 Dec 2024 · 11 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #66 · Compounds › Tirzepatide · 2 Dec 2024 · 0 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #27 · Practice › Reconstitution · 27 Nov 2024 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #31 · Access › Insurance & coverage · 18 Nov 2024 · 3 likes This follows post #28 rather than contradicting it. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria.…
-
EMA product information as a primary source — does this still hold? Replied, post #104 · Regional › European Union · 17 Nov 2024 · 2 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
EMA product information as a primary source — does this still hold? Replied, post #100 · Regional › European Union · 17 Nov 2024 · 3 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
-
Why "any advice?" is the least effective ending for a post Replied, post #30 · Start Here › How to Ask · 12 Nov 2024 · 0 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
When to suspect the method rather than the sample Replied, post #24 · Analytics › Method validation · 16 Oct 2024 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #34 · Compounds › Other compounds · 5 Oct 2024 · 11 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #11 · Clinical › Comorbidities · 30 Sep 2024 · 3 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #40 · Evidence › Preprints · 21 Sep 2024 · 12 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Chronic kidney disease and the FLOW result Replied, post #11 · Clinical › Comorbidities · 13 Aug 2024 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #46 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes Worth separating two things that post #42 runs together. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…